Lung cancer is still the top cancer killer, but new developments are shifting what the future might hold for patients.
About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in options over recent decades that have created meaningful improvements in lifespan ...
Initial evaluation prioritizes defining clinical stage, disease distribution, and optimal biopsy method, then individualizing sequencing of surgery, systemic therapy, and radiation based on ...
Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means treating a tumor with more than one type of therapy at the same time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results